Combination PPARγ and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2

Nuclear hormone receptors, including RXR and PPARγ, represent novel therapeutic targets in melanoma. We have previously shown that the DRO subline of the amelanotic melanoma A375 responds to rexinoid and thiazolidinedione (TZD) treatment in vitro and in vivo. We performed microarray analysis of A375...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Klopper, Joshua P., Sharma, Vibha, Bissonnette, Reid, Haugen, Bryan R.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2010
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2763133/
https://ncbi.nlm.nih.gov/pubmed/19859558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/729876
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires